Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Asep Medical Holdings Inc C.ASEP

Alternate Symbol(s):  SEPSF

ASEP Medical Holdings Inc. is a Canada-based company, which is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. The Company’s consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. It provides medical devices with an anti... see more

CSE:ASEP - Post Discussion

Asep Medical Holdings Inc > ASEP's diagnostic and therapeutic applications
View:
Post by waves1 on Jan 19, 2022 3:43pm

ASEP's diagnostic and therapeutic applications

$ASEP.c is trading at quite an attractive valuation right now given it's located in a market full of unmet needs.
 
As ASEP offers a rapid way to identify sepsis as well as treat it, they are positioned to win a meaningful share in the market. Their diagnostic application has a clear and easy path to generate revenue, which is notable given its commercialization is expected in mid-2022. Plus, ASEP's therapeutic product is expected to be fast-tracked to clinical trials within the next year as well.

https://asepmedical.com/investors/ 
Be the first to comment on this post
Asep Medical Holdings Inc